Daniel Barthelmes
VIENNA — A study conducted on a large database showed that the rate of endophthalmitis following intravitreal injections is low and does not increase with successive injections. A higher rate of noninfectious endophthalmitis was found with bevacizumab compared with other agents.
“Endophthalmitis is one of the most feared complications of intraocular procedures and anti-VEGF injections are no exception,” Daniel Barthelmes, MD, PhD, said at the Euretina meeting. “The increasing number of patients with neovascular AMD and the associated number of
Uncategorized